Immune-related pancreatitis in patients with advanced cancer treated with immune-checkpoint inhibitors.

Immune-related pancreatitis in patients with advanced cancer treated with immune-checkpoint inhibitors. - Immune-related pancreatitis

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051336

Enrollment

843

Registered

2023-06-13

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune-related pancreatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patiens who treated by immune checkpoint inhibitors.

Exclusion criteria

Exclusion criteria: Patients who have no clinical data

Design outcomes

Primary

Measure	Time frame
To clarify the current status of immune-related pancreatitis	—

Secondary

Measure	Time frame
Reveal the features of image findings of immune-related pancreatitis.	—

Countries

Japan

Contacts

Public ContactYasuki Hori

Nagoya City University Graduate School of Medical Sciences Gastroenterology and Metabolism

yhori@med.nagoya-cu.ac.jp+81528538211

Outcome results